RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Legislators, Regulators to Enhance Regulation of Anabolic Steroids

    • 01 August 2012
    Legislators and regulatory officials at the Drug Enforcement Administration (DEA) are both proposing to subject anabolic steroids to more stringent controls under the Controlled Substances Act (CSA) , according to documents filed in the Federal Register and at the Government Printing Office. DEA on 30 July released a final regulation classifying two additional anabolic steroids as Schedule II drugs under the CSA : prostanozol and methasterone. Under the definit...
  • DEA to Increase Supply of ADHD, Opioid Ingredients in Light of Shortages

    • 06 July 2012
    The US agency in charge of setting drug production quotas for substances regulated under the Controlled Substances Act (CSA) is proposing a mid-year adjustment in its production quotas for the active pharmaceutical ingredients contained within many attention deficit hyperactive disorder (ADHD) drugs and painkillers in response to growing drug shortages. In a 5 July 2012 Federal Register posting, the US Drug Enforcement Administration (DEA) announced it is looking to ...
  • FDA Looks to Reassess Hydrocodone Products

    The US Food and Drug Administration (FDA) is planning to revisit a benefit:risk assessment for a powerful painkiller subject to escalating amounts of addiction and abuse after the agency was pressed by a national drug control agency. In an 8 June Federal Register posting, FDA said it had been petitioned by the US Drug Enforcement Agency (DEA) to look at how the government classifies hydrocodone, which is subject to restrictions under the Controlled Substances Act (CSA...
  • Consumers Warned of Fake Adderall in US

    The US Food and Drug Administration (FDA) warned consumers on 29 May of counterfeit copies of Teva Pharmaceutical Industries' attention deficit hyperactive disorder (ADHD) drug Adderall, saying some consumers had obtained copies of the drug containing the incorrect active pharmaceutical ingredients (APIs) through an online pharmacy. ADHD drugs like Adderall use a combination of APIs known as amphetamine salts. In the case of Adderall, the drug contains dextroamphetamine ...
  • US DEA Releases Fee Schedule for Chemical Registrations

    The US Drug Enforcement Administration (DEA), a division of the US Department of Justice (DOJ), released an updated adjustment of the registration and reregistration fees associated with its Diversion Control Program on 13 March. The program is used by DEA to control the manufacture, distribution, dispensing, importation and exportation of controlled substances and List I chemicals. List I chemicals are those deemed to be important in the manufacture of controlled subst...
  • Judge Stops Company’s Drug Shipments in Florida

    • 02 March 2012
    A US District judge ordered Cardinal Health to stop shipping drugs from its Lakeland, FL, distribution center, according to a report in USA Today . The US Drug Enforcement Administration (DEA) had previously suspended the company's license to distribute prescription painkillers to Florida pharmacies. Judge Reggie Walton's decision upholds that suspension. A DEA investigation found Cardinal shipped 50 times as much oxycodone to four of its top pharmacies than it did t...
  • Import Regulations Used as Delaying Tactic in Nebraska Execution Case

    The state of Nebraska was the epicenter of a convergence between US Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) import regulations and death penalty politics on 9 January. Attorneys for death row inmate Michael Ryan had sued the state of Nebraska to produce documents proving that the state had legally obtained the execution drug sodium thiopental. Nebraska Attorney General Jon Bruning produced documents Monday showing that Nebraska had ...
  • ADHD Drugs Remain in Short Supply

    A shortage of a medication used to treat attention deficit hyperactive disorder (ADHD) shows little sign of abating as the US Drug Enforcement Administration (DEA) continues to regulate the amphetamine salts that act as the drug's active pharmaceutical ingredient (API). The DEA controls the supply of the amphetamine salts via a manufacturing quota system, and authorizes certain amounts of the amphetamine salts to be distributed based on what the agency determines to be t...